P = 0.002; 74.8 ± 7.6 to 70.4 ± 6.5 diastolic BP, P = 0.001). None of the women had a blood loss of >900 mL and no transfusions were required.These results agree with those from a previous randomized, controlled pilot study, leading to the conclusion that the use of sequential oxytocin and sublingual nitroglycerin seems to be effective and safe for retained placenta. One weakness of the present study is that no ultrasonography was performed when retained placenta was diagnosed. The authors recommended a large, randomized, placebo-controlled study of retained placenta using ultrasonography for diagnosis of the condition.
COMMENTThere are many agents that can be used to assist in delivering a retained placenta. These methods range from oxytocics, ergometrine, or prostaglandins to induce uterine contractions, which shear off and expel the placenta to glyceryl trinitrate (nitroglycerin), amyl nitrate, and inhalational agents to relax the uterus and cervix to expedite mechanical techniques-controlled cord traction, Crede's maneuver or manual removal-of placental expulsion.I remember, many moons ago, in the late 1980s/early 1990s, writing the early protocols to be followed for dilution, handling and administration of intravenous glyceryl trinitrate miniboluses for women with retained placentae. The use of nitroglycerin to relax the uterus is not new.Since nitroglycerin is a potent nitric oxide (NO) donor, it works not only by inducing transient relaxation of the uterine body but also by relaxing the anchoring villi and, therefore, encouraging placental separation. Placental separation is known to commence from the lower pole of the placenta by a multiphasic process where the central mechanism involves retroplacental myometrial contractions, which produce placental separation.The importance of this paper is that (a) it shows that sublingual nitroglycerin 1 mg is as effective as the minibolus intravenous route; (b) the technique is effective and simple (study success rate: pilot 12/12, main 21/24); and (c) the protocol is safe in that, if the guidelines are followed, hypotension is not severe and bleeding is not markedly increased.It should be remembered that, despite the paper's title, this is not a study of the efficacy of sublingual nitroglycerin in retained placenta but of the efficacy of sequential oxytocin followed by single-dose sublingual nitroglycerin. The piece de resistance of the paper lies in the simple protocol itself especially since the success rate is high and can dramatically reduce the need for postpartum general anesthesia or introduction of major neuraxial blockade.The protocol bears presenting in synopsis here: minutes after delivery, 5 IU oxytocin intramuscularly/IV followed by Crede's maneuver; after 30 minutes of failure to deliver the placenta, 10 IU oxytocin followed by controlled umbilical cord traction; after a further 20 to 30 minutes, sublingual nitroglycerin 1 mg tablet. Once the tablet is absorbed and is no longer visible under the tongue, wait for 5 minutes before reapplying controlled c...